CRISPR-Q
Live / Registered — Registered (as of 27 Sept 2022)
What this means for you
Registered since 27 Sept 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79326535
- Registration number
- 6854769
- Mark type
- Stylized text
- Filed
- 18 Jun 2021
- Published for opposition
- 12 Jul 2022
- Registered
- 27 Sept 2022
- Attorney of record
- Randolph E. Digges, III
Goods and services
- Class 001 — Chemicals: Chemical, biochemical and biotechnological diagnostic preparations for scientific use; non-medical reagents used in analytical chemistry, for scientific and/or medical research use for marking, separating, isolating, amplifying, cloning, sequencing and/or for the analysis of biopolymers in the nature of nucleic acids, in particular reagents, enzymes and buffer solutions for isolating, amplifying and analysing nucleic acids; chemical test kits for laboratory or research use for marking, separating, isolating, amplifying, cloning, sequencing and/or for the analysis of biopolymers in the nature of nucleic acids, in particular comprising reagents, enzymes and buffer solutions for isolating, amplifying and analysing nucleic acids
- Class 005 — Pharmaceuticals: Diagnostic preparations for medical and veterinary purposes, namely, diagnostic preparations for marking, separating, isolating, amplifying, cloning, sequencing and/or for the analysis of biopolymers in the nature of acids; diagnostic reagents, enzymes and buffer solutions for isolating, amplifying and analysing nucleic acids for medical or veterinary purposes; chemical, biochemical and biotechnological diagnostic preparations for medical and veterinary purposes, namely, reagents, enzymes and buffer solutions for marking, separating, isolating, amplifying, cloning, sequencing and/or for the analysis of biopolymers in the nature of nucleic acids; diagnostic kits containing preparations for medical and veterinary diagnostic purposes, namely, preparations for marking, separating, isolating, amplifying, cloning, sequencing and/or for the analysis of biopolymers in the nature of nucleic acids; diagnostic kits containing reagents, enzymes and buffer solutions for isolating, amplifying and analysing nucleic acids for medical or veterinary purposes
Owner
- Qiagen GmbH, DE
- Qiagen GmbH, DE
- Qiagen GmbH, DE
Prosecution history
- 14 Feb 2023 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 25 Jan 2023 — FINAL DISPOSITION NOTICE SENT TO IB
- 25 Jan 2023 — FINAL DISPOSITION PROCESSED
- 27 Dec 2022 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 27 Sept 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 27 Sept 2022 — REGISTERED-PRINCIPAL REGISTER
- 19 Jul 2022 — NOTIFICATION PROCESSED BY IB
- 12 Jul 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Jul 2022 — PUBLISHED FOR OPPOSITION
- 29 Jun 2022 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 29 Jun 2022 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 22 Jun 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Jun 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 May 2022 — REFUSAL PROCESSED BY IB
- 12 May 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED